LOXL2 and hepatocellular carcinoma: In HCC patients who underwent curative resection, factors including FGF3, FGFR2, Lysyl-oxidase-like (LOXL)-2, klotho-β, and FGF19 indicate a higher risk of tumor recurrence and worse survival rate.